Literature DB >> 22145575

Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery.

David R Hall1, Chi Ho Ngan, Brandon S Zerbe, Dima Kozakov, Sandor Vajda.   

Abstract

Fragment-based drug design (FBDD) starts with finding fragment-sized compounds that are highly ligand efficient and can serve as a core moiety for developing high-affinity leads. Although the core-bound structure of a protein facilitates the construction of leads, effective design is far from straightforward. We show that protein mapping, a computational method developed to find binding hot spots and implemented as the FTMap server, provides information that complements the fragment screening results and can drive the evolution of core fragments into larger leads with a minimal loss or, in some cases, even a gain in ligand efficiency. The method places small molecular probes, the size of organic solvents, on a dense grid around the protein and identifies the hot spots as consensus clusters formed by clusters of several probes. The hot spots are ranked based on the number of probe clusters, which predicts the binding propensity of the subsites and hence their importance for drug design. Accordingly, with a single exception the main hot spot identified by FTMap binds the core compound found by fragment screening. The most useful information is provided by the neighboring secondary hot spots, indicating the regions where the core can be extended to increase its affinity. To quantify this information, we calculate the density of probes from mapping, which describes the binding propensity at each point, and show that the change in the correlation between a ligand position and the probe density upon extending or repositioning the core moiety predicts the expected change in ligand efficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22145575      PMCID: PMC3264775          DOI: 10.1021/ci200468p

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  57 in total

Review 1.  Structural biology in fragment-based drug design.

Authors:  Christopher W Murray; Tom L Blundell
Journal:  Curr Opin Struct Biol       Date:  2010-05-12       Impact factor: 6.809

Review 2.  Computational approaches for fragment-based and de novo design.

Authors:  Kathryn Loving; Ian Alberts; Woody Sherman
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

3.  Docking performance of fragments and druglike compounds.

Authors:  Marcel L Verdonk; Ilenia Giangreco; Richard J Hall; Oliver Korb; Paul N Mortenson; Christopher W Murray
Journal:  J Med Chem       Date:  2011-07-06       Impact factor: 7.446

Review 4.  Drugging challenging targets using fragment-based approaches.

Authors:  Anthony G Coyne; Duncan E Scott; Chris Abell
Journal:  Curr Opin Chem Biol       Date:  2010-03-10       Impact factor: 8.822

Review 5.  The benefits of constructing leads from fragment hits.

Authors:  N Foloppe
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

Review 6.  The rise of fragment-based drug discovery.

Authors:  Christopher W Murray; David C Rees
Journal:  Nat Chem       Date:  2009-06       Impact factor: 24.427

7.  Experiences in fragment-based lead discovery.

Authors:  Roderick E Hubbard; James B Murray
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

8.  Structural conservation of druggable hot spots in protein-protein interfaces.

Authors:  Dima Kozakov; David R Hall; Gwo-Yu Chuang; Regina Cencic; Ryan Brenke; Laurie E Grove; Dmitri Beglov; Jerry Pelletier; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

9.  The structural basis of pregnane X receptor binding promiscuity.

Authors:  Chi-Ho Ngan; Dmitri Beglov; Aleksandra N Rudnitskaya; Dima Kozakov; David J Waxman; Sandor Vajda
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

10.  Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.

Authors:  Gwo-Yu Chuang; Dima Kozakov; Ryan Brenke; Dmitri Beglov; Frank Guarnieri; Sandor Vajda
Journal:  Biophys J       Date:  2009-11-18       Impact factor: 4.033

View more
  24 in total

1.  Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces.

Authors:  Brandon S Zerbe; David R Hall; Sandor Vajda; Adrian Whitty; Dima Kozakov
Journal:  J Chem Inf Model       Date:  2012-07-24       Impact factor: 4.956

2.  Ligand deconstruction: Why some fragment binding positions are conserved and others are not.

Authors:  Dima Kozakov; David R Hall; Stefan Jehle; Sefan Jehle; Lingqi Luo; Stefan O Ochiana; Elizabeth V Jones; Michael Pollastri; Karen N Allen; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

3.  Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).

Authors:  Mengqi Zhong; Andrew Lynch; Samantha N Muellers; Stefan Jehle; Lingqi Luo; David R Hall; Reina Iwase; James P Carolan; Megan Egbert; Amanda Wakefield; Kristina Streu; Christine M Harvey; Paula C Ortet; Dima Kozakov; Sandor Vajda; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

4.  FTFlex: accounting for binding site flexibility to improve fragment-based identification of druggable hot spots.

Authors:  Laurie E Grove; David R Hall; Dmitri Beglov; Sandor Vajda; Dima Kozakov
Journal:  Bioinformatics       Date:  2013-03-07       Impact factor: 6.937

5.  Energy Minimization on Manifolds for Docking Flexible Molecules.

Authors:  Hanieh Mirzaei; Shahrooz Zarbafian; Elizabeth Villar; Scott Mottarella; Dmitri Beglov; Sandor Vajda; Ioannis Ch Paschalidis; Pirooz Vakili; Dima Kozakov
Journal:  J Chem Theory Comput       Date:  2015-03-10       Impact factor: 6.006

6.  Ensemble docking to difficult targets in early-stage drug discovery: Methodology and application to fibroblast growth factor 23.

Authors:  Hector A Velazquez; Demian Riccardi; Zhousheng Xiao; Leigh Darryl Quarles; Charless Ryan Yates; Jerome Baudry; Jeremy C Smith
Journal:  Chem Biol Drug Des       Date:  2017-11-03       Impact factor: 2.817

7.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins.

Authors:  Dima Kozakov; Laurie E Grove; David R Hall; Tanggis Bohnuud; Scott E Mottarella; Lingqi Luo; Bing Xia; Dmitri Beglov; Sandor Vajda
Journal:  Nat Protoc       Date:  2015-04-09       Impact factor: 13.491

8.  Rigid Body Energy Minimization on Manifolds for Molecular Docking.

Authors:  Hanieh Mirzaei; Dmitri Beglov; Ioannis Ch Paschalidis; Sandor Vajda; Pirooz Vakili; Dima Kozakov
Journal:  J Chem Theory Comput       Date:  2012-08-21       Impact factor: 6.006

9.  PoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity.

Authors:  Ambrish Roy; Bharath Srinivasan; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2015-08-12       Impact factor: 4.956

10.  Stimulators of translation identified during a small molecule screening campaign.

Authors:  Unkyung Shin; David E Williams; Dima Kozakov; David R Hall; Dmitri Beglov; Sandor Vajda; Raymond J Andersen; Jerry Pelletier
Journal:  Anal Biochem       Date:  2014-02-15       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.